Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: NI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on NI, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 2,164,103 NI shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,164,103 shares
    Change vs previous 13F +66,105 shares

    1.89% of the 13F portfolio, value $102,903,098.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,097,998 shares
    Change vs previous 13F +14,781 shares

    1.88% of the 13F portfolio, value $97,892,587.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,083,217 shares
    Change vs previous 13F +141,425 shares

    1.83% of the 13F portfolio, value $87,001,665.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,941,792 shares
    Change vs previous 13F not available

    1.89% of the 13F portfolio, value $84,085,937.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).